Promomed’s launch in Uzbekistan reflects growing international interest in the country’s healthcare system. For the market, this means not only new brands entering the landscape, but also stronger competition in the segment of modern medicines.

Projects of this kind usually drive partner-network development, regulatory work, medical marketing, and closer engagement with clinics. That raises expectations for distribution quality, service speed, and transparency across the supply chain.

For the B2B medical supply market, this is a sign that Uzbekistan is viewed as a long-term growth destination. The more international manufacturers enter the country, the more valuable experienced distributors become for compliance, logistics, and in-market product support.